Several retrospective analyses have already been reported showing that breast cancer patients have worse outcomes as HER2 levels increase (Gilcrease et al., 2009; Rossi et al., 2012; Eggemann et al., 2015). The gene discussed is ERBB2; the disease is breast carcinoma.